Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 Feb;32(2):265–267. doi: 10.1128/aac.32.2.265

Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus.

J C Lin 1, Z X Zhang 1, M C Smith 1, K Biron 1, J S Pagano 1
PMCID: PMC172149  PMID: 2834997

Abstract

We show that the anti-human immunodeficiency virus agent, 3'-azido-3'-deoxythymidine (AZT), which suppresses infectivity and cytopathic effects of human immunodeficiency virus, also effectively inhibits Epstein-Barr virus (EBV) DNA replication. However, AZT has no effect on four other human herpesviruses: cytomegalovirus, varicella-zoster virus, and herpes simplex virus types 1 and 2. The combination of acyclovir and AZT, while it is not synergistic, has an additive effect against EBV replication. AZT may prove to be a useful drug for treatment of coinfections with human immunodeficiency virus and EBV.

Full text

PDF
265

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C., Séguin C. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 1984 Jul 19;310(5974):207–211. doi: 10.1038/310207a0. [DOI] [PubMed] [Google Scholar]
  2. Biron K. K., Elion G. B. In vitro susceptibility of varicella-zoster virus to acyclovir. Antimicrob Agents Chemother. 1980 Sep;18(3):443–447. doi: 10.1128/aac.18.3.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. De Clercq E., Descamps J., Verhelst G., Walker R. T., Jones A. S., Torrence P. F., Shugar D. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. J Infect Dis. 1980 May;141(5):563–574. doi: 10.1093/infdis/141.5.563. [DOI] [PubMed] [Google Scholar]
  4. Elion G. B., Furman P. A., Fyfe J. A., de Miranda P., Beauchamp L., Schaeffer H. J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716–5720. doi: 10.1073/pnas.74.12.5716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ernberg I., Andersson J. Acyclovir efficiently inhibits oropharyngeal excretion of Epstein-Barr virus in patients with acute infectious mononucleosis. J Gen Virol. 1986 Oct;67(Pt 10):2267–2272. doi: 10.1099/0022-1317-67-10-2267. [DOI] [PubMed] [Google Scholar]
  6. Furman P. A., Fyfe J. A., St Clair M. H., Weinhold K., Rideout J. L., Freeman G. A., Lehrman S. N., Bolognesi D. P., Broder S., Mitsuya H. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8333–8337. doi: 10.1073/pnas.83.21.8333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gibbs J. S., Chiou H. C., Hall J. D., Mount D. W., Retondo M. J., Weller S. K., Coen D. M. Sequence and mapping analyses of the herpes simplex virus DNA polymerase gene predict a C-terminal substrate binding domain. Proc Natl Acad Sci U S A. 1985 Dec;82(23):7969–7973. doi: 10.1073/pnas.82.23.7969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Greenspan J. S., Greenspan D., Lennette E. T., Abrams D. I., Conant M. A., Petersen V., Freese U. K. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med. 1985 Dec 19;313(25):1564–1571. doi: 10.1056/NEJM198512193132502. [DOI] [PubMed] [Google Scholar]
  9. Groopman J. E., Sullivan J. L., Mulder C., Ginsburg D., Orkin S. H., O'Hara C. J., Falchuk K., Wong-Staal F., Gallo R. C. Pathogenesis of B cell lymphoma in a patient with AIDS. Blood. 1986 Mar;67(3):612–615. [PubMed] [Google Scholar]
  10. Hartshorn K. L., Sandstrom E. G., Neumeyer D., Paradis T. J., Chou T. C., Schooley R. T., Hirsch M. S. Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon. Antimicrob Agents Chemother. 1986 Jul;30(1):189–191. doi: 10.1128/aac.30.1.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lin J. C., Nelson D. J., Lambe C. U., Choi E. I. Metabolic activation of 9([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human lymphoblastoid cell lines infected with Epstein-Barr virus. J Virol. 1986 Nov;60(2):569–573. doi: 10.1128/jvi.60.2.569-573.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lin J. C., Pagano J. S. Cellular transformation by the herpesviruses and antiviral drugs. Pharmacol Ther. 1985;28(2):135–161. doi: 10.1016/0163-7258(85)90010-5. [DOI] [PubMed] [Google Scholar]
  13. Lin J. C., Smith M. C., Cheng Y. C., Pagano J. S. Epstein-Barr virus: inhibition of replication by three new drugs. Science. 1983 Aug 5;221(4610):578–579. doi: 10.1126/science.6306771. [DOI] [PubMed] [Google Scholar]
  14. Lin J. C., Smith M. C., Choi E. I., De Clercq E., Verbruggen A., Pagano J. S. Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on replication of Epstein-Barr virus in human lymphoblastoid cell lines. Antiviral Res. 1985;Suppl 1:121–126. doi: 10.1016/s0166-3542(85)80018-8. [DOI] [PubMed] [Google Scholar]
  15. Lin J. C., Smith M. C., Pagano J. S. Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus. Antimicrob Agents Chemother. 1985 Jun;27(6):971–973. doi: 10.1128/aac.27.6.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lin J. C., Smith M. C., Pagano J. S. Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus. J Virol. 1984 Apr;50(1):50–55. doi: 10.1128/jvi.50.1.50-55.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mar E. C., Patel P. C., Huang E. S. Effect of 9-(2-hydroxyethoxymethyl)guanine on viral-specific polypeptide synthesis in human cytomegalovirus-infected cells. Am J Med. 1982 Jul 20;73(1A):82–85. doi: 10.1016/0002-9343(82)90069-9. [DOI] [PubMed] [Google Scholar]
  18. Mitsuya H., Weinhold K. J., Furman P. A., St Clair M. H., Lehrman S. N., Gallo R. C., Bolognesi D., Barry D. W., Broder S. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci U S A. 1985 Oct;82(20):7096–7100. doi: 10.1073/pnas.82.20.7096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pagano J. S., Sixbey J. W., Lin J. C. Acyclovir and Epstein-Barr virus infection. J Antimicrob Chemother. 1983 Sep;12 (Suppl B):113–121. doi: 10.1093/jac/12.suppl_b.113. [DOI] [PubMed] [Google Scholar]
  20. Resnick L., Markham P. D., Veren K., Salahuddin S. Z., Gallo R. C. In vitro suppression of HTLV-III/LAV infectivity by a combination of acyclovir and suramin. J Infect Dis. 1986 Dec;154(6):1027–1030. doi: 10.1093/infdis/154.6.1027. [DOI] [PubMed] [Google Scholar]
  21. Rubinstein A., Morecki R., Silverman B., Charytan M., Krieger B. Z., Andiman W., Ziprkowski M. N., Goldman H. Pulmonary disease in children with acquired immune deficiency syndrome and AIDS-related complex. J Pediatr. 1986 Apr;108(4):498–503. doi: 10.1016/s0022-3476(86)80822-8. [DOI] [PubMed] [Google Scholar]
  22. Vogt M. W., Hartshorn K. L., Furman P. A., Chou T. C., Fyfe J. A., Coleman L. A., Crumpacker C., Schooley R. T., Hirsch M. S. Ribavirin antagonizes the effect of azidothymidine on HIV replication. Science. 1987 Mar 13;235(4794):1376–1379. doi: 10.1126/science.2435003. [DOI] [PubMed] [Google Scholar]
  23. Yarchoan R., Klecker R. W., Weinhold K. J., Markham P. D., Lyerly H. K., Durack D. T., Gelmann E., Lehrman S. N., Blum R. M., Barry D. W. Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet. 1986 Mar 15;1(8481):575–580. doi: 10.1016/s0140-6736(86)92808-4. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES